MIA researchers feature on prestigious Highly Cited Researchers 2020 List
18 November 2020
Melanoma Institute Australia is proud to announce that MIA’s Co-Medical Directors, Professor Georgina Long AO and Professor Richard Scolyer, as well as MIA Faculty member Associate Professor Alex Menzies and former Faculty member Professor Rick Kefford AM, have been named on the annual Highly Cited Researchers™ 2020 list from Clarivate.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe. It identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade.
Their names are drawn from the publications that rank in the top 1% by citations for field and publication year in the Web of Science™ citation index.
According to Clarivate, 6,167 researchers from more than 60 countries and regions have been recognized this year, with Australian research institutes continuing to punch above their weight. In a country of just 25 million, the number of Australian researchers recognized in 2020 is 305.
MIA Co-Medical Director Professor Georgina Long AO, whose video interview with Clarivate is featured online, said:
“This accolade is recognition of the ground-breaking work being carried out by the entire team at Melanoma Institute Australia as we continue our quest to develop treatments that will ultimately save the lives of all melanoma patients.”
Fellow Co-Medical Director of MIA Professor Richard Scolyer said:
“It is an honour to again be included on this list alongside several other MIA researchers and clinicians. It shows the phenomenal and ongoing impact that MIA’s work and research is having around the world.”
David Pendlebury, Senior Citation Analyst at the Institute for Scientific Information at Clarivate said:
“In the race for knowledge, it is human capital that is fundamental and this list identifies and celebrates exceptional individual researchers from Melanoma Institute Australia who are having a great impact on the research community as measured by the rate at which their work is being cited by others.”
Melanoma Institute Australia is affiliated with The University of Sydney
#HighlyCited2020
Sunrise features inspiring story of MIA patient
Melanoma Institute Australia (MIA) patient Tara Moran and her seven year old daughter Olivia, who is fundraising for MIA, have been in the national media spotlight this week.
Dr James Wilmott wins award for Outstanding Cancer Research
Dr James Wilmott was awarded the Wildfire Award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
Tune into Jay's Longest Melanoma March Channel 10 documentary - Copy
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
Overcoming resistance to immunotherapy. - Copy
New research takes on major challenge to improving survival in melanoma.
Overcoming resistance to immunotherapy. - Copy
New research takes on major challenge to improving survival in melanoma.
Overcoming resistance to immunotherapy. - Copy
New research takes on major challenge to improving survival in melanoma.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
All Aussies should have access to this lifesaver
Carrie Palmer writes for The Daily Telegraph about her experience with melanoma.
15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma
Julie-Ann Sams knows all too well that melanoma doesn’t discriminate. Life changed for her
youngest son, Toby Rayner, when he was diagnosed with a rare from of iris melanoma that sadly required his left eye to be surgically removed.
15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma
Julie-Ann Sams knows all too well that melanoma doesn’t discriminate. Life changed for her
youngest son, Toby Rayner, when he was diagnosed with a rare from of iris melanoma that sadly required his left eye to be surgically removed.
Congratulations to our Conjoint Medical Directors
Our Conjoint Medical Directors have been announced as Fellows of the Australian Academy of Health and Medical Sciences.
Melanoma diagnosis for Australian Survivor Contestant stark warning about the risks of sun exposure
News reports today of a recently evicted Australian Survivor star being diagnosed with melanoma should serve as a stark warning to all Australians of the serious health risks posed by sun exposure.
60 Minutes' MIA Patient Feature Program
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
The latest research from Dr James Wilmott
Dr James Wilmott is researching how melanoma forms in young people.
Jay Allen MIA's Community Coordinator nominated for NSW Australian of the Year award
Congratulations to MIA’s Community Coordinator and melanoma survivor Jay Allen who has been announced as a nominee for the 2018 Australian of the Year Awards.
First patient recruited to the EAGLE FM Trial
Evaluation of Groin Lymphadenectomy Extent for Metastatic Melanoma (EAGLE FM) clinical trial has recruited its first patient.